Corvus Pharmaceuticals
CRVS
CRVS
47 hedge funds and large institutions have $18.5M invested in Corvus Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
18% less funds holding
Funds holding: 57 → 47 (-10)
59% less capital invested
Capital invested by funds: $44.9M → $18.5M (-$26.5M)
69% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 13
Holders
47
Holding in Top 10
1
Calls
$80K
Puts
$60K
Top Buyers
| 1 | +$627K | |
| 2 | +$245K | |
| 3 | +$212K | |
| 4 |
Renaissance Technologies
New York
|
+$75.8K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$24.2K |
Top Sellers
| 1 | -$1.22M | |
| 2 | -$837K | |
| 3 | -$813K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$496K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$229K |